Clinical Trial Update: Effects of Vitamin D3 and Prebiotics Supplementation on Cardiovascular Risk Factors in Patients With Type 2 Diabetes [NA]

View source ↗

Summary

Completed clinical trial assessing whether Vitamin D3 and prebiotics influence cardiovascular risk factors in patients with Type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Prebiotic supplement (prebiotic)
• Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: Huazhong University of Science and Technology | Conditions: Diabetes Mellitus, Type 2 | NA | Status: COMPLETED